Metraipolis › archive › dc_f302e6fba185
The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease… — Europe PMC PMID:41682243
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41682243
- DOI
- 10.3390/healthcare14030393
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-06T03:23:39.036Z
- SHA-256 of the archived text
adff9a01199f8bb8e816a3db9ef6142c64e15d7f8de92fa2d0144119643533e6- Stable URL of this page
https://metraipolis.com/documento/dc_f302e6fba185
How to cite
The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease… — Europe PMC PMID:41682243 — Europe PMC (en), https://europepmc.org/article/MED/41682243 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f302e6fba185 (Metraipolis archive dc_f302e6fba185, sha256 adff9a01199f8bb8e816a3db9ef6142c64e15d7f8de92fa2d0144119643533e6)
BibTeX
@misc{dcf302e6fba185,
title = {The Significance of Hypophosphatemia in Deciding on an Optimal Clinical Choice of Parenteral Iron Therapy in Patients with Chronic Inflammatory Bowel Disease… — Europe PMC PMID:41682243},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41682243},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f302e6fba185; sha256 adff9a01199f8bb8e816a3db9ef6142c64e15d7f8de92fa2d0144119643533e6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41682243. Agents can read the archived copy with the MCP tool read_document.